Agency Forms Undergoing Paperwork Reduction Act Review, 66030-66031 [2016-23072]
Download as PDF
<![CDATA[
mstockstill on DSK3G9T082PROD with NOTICES
66030
Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
of the meeting will be included in the
official record of the meeting.
The meeting will be webcast live via
the World Wide Web; for instructions
and more information on ACIP please
visit the ACIP Web site: https://
www.cdc.gov/vaccines/acip/.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate use of immunizing agents.
In addition, under 42 U.S.C. §1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines. Further, under provisions of
the Affordable Care Act, at section 2713
of the Public Health Service Act,
immunization recommendations of the
ACIP that have been adopted by the
Director of the Centers for Disease
Control and Prevention and appear on
the CDC immunization schedules must
be covered by applicable health plans.
Matters for Discussion: The agenda
will include discussions on:
Meningococcal vaccines; human
papillomavirus vaccines; influenza;
hepatitis vaccines; pertussis vaccines;
Respiratory Syncytial Virus (RSV); child
and adolescent immunization schedule;
adult immunization schedule; herpes
zoster vaccine; yellow fever vaccine;
pneumococcal vaccine and vaccine
supply. A recommendation vote is
scheduled for Hepatitis B vaccine,
pertussis vaccine, human
papillomavirus vaccines, meningococcal
vaccines, child and adolescent
immunization schedule, and adult
immunization schedule. A Vaccines for
Children (VFC) vote is scheduled for
human papillomavirus vaccines,
Hepatitis B vaccine and meningococcal
vaccines. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, Telephone:
(404) 639–8836; Email: ACIP@
CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
VerDate Sep<11>2014
19:40 Sep 23, 2016
Jkt 238001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23053 Filed 9–23–16; 8:45 am]
[FR Doc. 2016–23055 Filed 9–23–16; 8:45 am]
BILLING CODE 4160–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) GH16–007, Operations Research
(Implementation Science) for
Strengthening Global Health Protection
Implementation.
Times and dates: 9:00 a.m.–2:00 p.m.,
EDT, Panel A, October 18, 2016
(Closed); 9:00 a.m.–2:00 p.m., EDT,
Panel B, October 19, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
GH16–007 Operations Research
(Implementation Science) for
Strengthening Global Health Protection
Implementation.
Contact person for more information:
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30329, Telephone: (404) 639–4796.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0457]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
E:\FR\FM\26SEN1.SGM
26SEN1
66031
Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
comments should be received within 30
days of this notice.
Proposed Project
Aggregate Reports for Tuberculosis
Program Evaluation (OMB Control
Number 0920–0457)—Reinstatement
Without Change of a Previously
Approved Collection—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC, NCHHSTP, Division of
Tuberculosis Elimination (DTBE)
proposes a reinstatement without
change of the Aggregate Reports for
Tuberculosis Program Evaluation,
previously approved under OMB
Control Number 0920–0457. This
request is for a three-year clearance.
There are no revisions to the report
forms, data definitions, or reporting
instructions.
DTBE is the lead agency for
tuberculosis elimination in the United
States. To ensure the elimination of
tuberculosis in the United States, CDC
monitors indicators for key program
activities, such as finding tuberculosis
infections in recent contacts of cases
and in other persons likely to be
infected and providing therapy for
latent tuberculosis infection.
In 2000, CDC implemented two
program evaluation reports for annual
submission: Aggregate report of followup for contacts of tuberculosis, and
Aggregate report of screening and
preventive therapy for tuberculosis
infection (OMB No. 0920–0457). The
respondents for these reports were the
68 state and local tuberculosis control
programs receiving federal cooperative
agreement funding through DTBE. This
group will also respond to this
collection of information.
These Aggregate reports emphasize
treatment outcomes, high-priority target
populations vulnerable to tuberculosis,
and programmed electronic report entry,
which transitioned to the National
Tuberculosis Indicators Project (NTIP), a
secure web-based system for program
evaluation data, in 2010. No other
federal agency collects this type of
national tuberculosis data, and the
Aggregate report of follow-up for
contacts of tuberculosis, and Aggregate
report of screening and preventive
therapy for tuberculosis infection are
the only data source about latent
tuberculosis infection for monitoring
national progress toward tuberculosis
elimination with these activities.
CDC provides ongoing assistance in
the preparation and utilization of these
reports at the local and state levels of
public health jurisdiction. CDC also
provides respondents with technical
support for NTIP access (Electronic—
100%, Use of Electronic Signatures).
The annual burden to respondents is
estimated to be 226 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Data clerks and Program Managers
(electronic).
Program Managers (manual) ............
Data clerks (manual) .........................
Data clerks and Program Managers
(electronic).
Program Managers (manual) ............
Data clerks (manual) .........................
Number of
responses per
respondent
Tuberculosis
100
1
30/60
Tuberculosis
18
1
30/60
Tuberculosis
18
1
3
Tuberculosis
100
1
30/60
Tuberculosis
18
1
30/60
Tuberculosis
Follow-up and Treatment of Contacts to
Cases Form.
Follow-up and Treatment of Contacts to
Cases Form.
Follow-up and Treatment of Contacts to
Cases Form.
Targeted Testing and Treatment for Latent
Infection.
Targeted Testing and Treatment for Latent
Infection.
Targeted Testing and Treatment for Latent
Infection.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23072 Filed 9–23–16; 8:45 am]
BILLING CODE 4163–18–P
18
1
3
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–R–70, CMS–R–
72, CMS–R–247, CMS–10062, CMS–10268,
CMS–10615 and CMS–10623]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services.
ACTION: Notice.
mstockstill on DSK3G9T082PROD with NOTICES
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
SUMMARY:
VerDate Sep<11>2014
19:40 Sep 23, 2016
Jkt 238001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Number of
respondents
Form name
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Pages 66030-66031]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23072]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0457]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
[[Page 66031]]
comments should be received within 30 days of this notice.
Proposed Project
Aggregate Reports for Tuberculosis Program Evaluation (OMB Control
Number 0920-0457)--Reinstatement Without Change of a Previously
Approved Collection--National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC, NCHHSTP, Division of Tuberculosis Elimination (DTBE) proposes
a reinstatement without change of the Aggregate Reports for
Tuberculosis Program Evaluation, previously approved under OMB Control
Number 0920-0457. This request is for a three-year clearance. There are
no revisions to the report forms, data definitions, or reporting
instructions.
DTBE is the lead agency for tuberculosis elimination in the United
States. To ensure the elimination of tuberculosis in the United States,
CDC monitors indicators for key program activities, such as finding
tuberculosis infections in recent contacts of cases and in other
persons likely to be infected and providing therapy for latent
tuberculosis infection.
In 2000, CDC implemented two program evaluation reports for annual
submission: Aggregate report of follow-up for contacts of tuberculosis,
and Aggregate report of screening and preventive therapy for
tuberculosis infection (OMB No. 0920-0457). The respondents for these
reports were the 68 state and local tuberculosis control programs
receiving federal cooperative agreement funding through DTBE. This
group will also respond to this collection of information.
These Aggregate reports emphasize treatment outcomes, high-priority
target populations vulnerable to tuberculosis, and programmed
electronic report entry, which transitioned to the National
Tuberculosis Indicators Project (NTIP), a secure web-based system for
program evaluation data, in 2010. No other federal agency collects this
type of national tuberculosis data, and the Aggregate report of follow-
up for contacts of tuberculosis, and Aggregate report of screening and
preventive therapy for tuberculosis infection are the only data source
about latent tuberculosis infection for monitoring national progress
toward tuberculosis elimination with these activities.
CDC provides ongoing assistance in the preparation and utilization
of these reports at the local and state levels of public health
jurisdiction. CDC also provides respondents with technical support for
NTIP access (Electronic--100%, Use of Electronic Signatures).
The annual burden to respondents is estimated to be 226 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response
respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Data clerks and Program Managers Follow-up and Treatment of 100 1 30/60
(electronic). Contacts to Tuberculosis
Cases Form.
Program Managers (manual)............... Follow-up and Treatment of 18 1 30/60
Contacts to Tuberculosis
Cases Form.
Data clerks (manual).................... Follow-up and Treatment of 18 1 3
Contacts to Tuberculosis
Cases Form.
Data clerks and Program Managers Targeted Testing and 100 1 30/60
(electronic). Treatment for Latent
Tuberculosis Infection.
Program Managers (manual)............... Targeted Testing and 18 1 30/60
Treatment for Latent
Tuberculosis Infection.
Data clerks (manual).................... Targeted Testing and 18 1 3
Treatment for Latent
Tuberculosis Infection.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-23072 Filed 9-23-16; 8:45 am]
BILLING CODE 4163-18-P
